Prognostic value of CEC count in HER2-negative metastatic breast cancer patients treated with bevacizumab and chemotherapy: a prospective validation study (UCBG COMET)
Nom du journal : Angiogenesis
Année : 2019
Volume : doi: 10.1007/s10456-019-09697-7 [Epub ahead of print]